Supplemental material
Open access
2,262
Views
19
CrossRef citations to date
0
Altmetric
Research Paper
Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series
Ashok Aspatwara Faculty of Medicine and Health Technology, Tampere University, Tampere, FinlandCorrespondence[email protected]
https://orcid.org/0000-0002-6938-7835View further author information
, https://orcid.org/0000-0002-6938-7835View further author information
Nanda Kumar Parvathanenib Department of Precision Medicine, The M-Lab, GROW – School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University Medical Centre, Maastricht, The Netherlands;c Institut des Biomolécules, Max Mousseron (IBMM) UMR 5247 CNRS, ENSCM, Université de Montpellier, Bâtiment de Recherche Max Mousseron, Ecole Nationale Supérieure de Montpellier, Montpellier, FranceView further author information
, Harlan Barkera Faculty of Medicine and Health Technology, Tampere University, Tampere, FinlandView further author information
, Emilie Anduranb Department of Precision Medicine, The M-Lab, GROW – School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University Medical Centre, Maastricht, The Netherlands;c Institut des Biomolécules, Max Mousseron (IBMM) UMR 5247 CNRS, ENSCM, Université de Montpellier, Bâtiment de Recherche Max Mousseron, Ecole Nationale Supérieure de Montpellier, Montpellier, FranceView further author information
, Claudiu T. Supurand NEUROFARBA Department, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Polo Scientifico, Firenze, Italyhttps://orcid.org/0000-0003-4262-0323View further author information
, Ludwig Duboisb Department of Precision Medicine, The M-Lab, GROW – School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University Medical Centre, Maastricht, The Netherlandshttps://orcid.org/0000-0002-8887-4137View further author information
, Philippe Lambinb Department of Precision Medicine, The M-Lab, GROW – School for Oncology and Developmental Biology, Maastricht Comprehensive Cancer Centre, Maastricht University Medical Centre, Maastricht, The NetherlandsView further author information
, Seppo Parkkilaa Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland;e Fimlab Ltd and Tays Cancer Center, Tampere University Hospital, Tampere, Finlandhttps://orcid.org/0000-0001-7323-8536View further author information
& Jean-Yves Winumc Institut des Biomolécules, Max Mousseron (IBMM) UMR 5247 CNRS, ENSCM, Université de Montpellier, Bâtiment de Recherche Max Mousseron, Ecole Nationale Supérieure de Montpellier, Montpellier, FranceCorrespondence[email protected]
https://orcid.org/0000-0003-3197-3414View further author information
show allhttps://orcid.org/0000-0003-3197-3414View further author information
Pages 109-117
|
Received 27 Sep 2019, Accepted 22 Oct 2019, Published online: 05 Nov 2019
Related Research Data
A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
Source:
Springer Science and Business Media LLC
Carbonic anhydrase inhibitors and activators for novel therapeutic applications
Source:
Future Science Ltd
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
Source:
American Chemical Society (ACS)
Validation in Support of Internationally Harmonised OECD Test Guidelines for Assessing the Safety of Chemicals.
Source:
Springer International Publishing
Perspectives on carbonic anhydrase
Source:
Elsevier BV
Novel nitroimidazole alkylsulfonamides as hypoxic cell radiosensitisers.
Source:
Elsevier BV
Dose-Response Analysis Using R
Source:
Public Library of Science (PLoS)
Nitroimidazoles as anti-tumor agents.
Source:
Bentham Science Publishers Ltd.
Insights into the binding mode of sulphamates and sulphamides to hCA II: crystallographic studies and binding free energy calculations
Source:
Taylor & Francis Group
Fluorinated benzenesulfonamide anticancer inhibitors of carbonic anhydrase IX exhibit lower toxic effects on zebrafish embryonic development than ethoxzolamide
Source:
Informa UK Limited
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Source:
Springer Science and Business Media LLC
Carbonic anhydrase related proteins: molecular biology and evolution.
Source:
Springer Netherlands
Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates
Source:
American Chemical Society (ACS)
Carbonic anhydrase IX inhibitors in cancer therapy: an update
Source:
Future Science Ltd
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.